TG Therapeutics | TGTX - Stock

Stock Price
28.88
Daily Change
1.12 4.03%
Monthly
-4.81%
Yearly
-12.72%
Q1 Forecast
28.52

TG Therapeutics reported $146.95M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
AbbVie USD 4.94B 22M Sep/2025
Amgen USD 6.22B 121M Dec/2025
Ardelyx USD 129.36M 107.08M Sep/2025
Arrowhead Research USD -173.08M 173.08M Dec/2024
Bayer EUR 12.33B 221M Sep/2025
Biogen USD 2.17B 41.3M Dec/2025
Corcept Therapeutics USD 12.35M 73K Sep/2025
Dynavax Technologies USD 73.29M 2.4M Sep/2025
Gilead Sciences USD 1.78B 40M Sep/2025
J&J USD 14.15B 734M Sep/2025
Novartis USD 6.42B 114M Sep/2025
PTC Therapeutics USD 52.69M 18.63M Sep/2025
Regeneron Pharmaceuticals USD 3.2B 53.6M Dec/2025
Roche Holding CHF 7.6B 9M Jun/2025
TG Therapeutics USD 146.95M 8.25M Sep/2025
Vertex Pharmaceuticals USD 1.63B 127.5M Sep/2025